Nassiri Amir Ahmad, Lotfollahi Legha, Bakhshayeshkaram Mehrdad, Kiani Arda, Haghighi Shirin, Alavi Darazam Ilad, Rashidfarokhi Farin
Department of Nephrology and Dialysis, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Chronic Respiratory Diseases Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tanaffos. 2015;14(3):213-6.
Renal lymphangiectasia is a disorder of the lymphatic system of the kidneys, which can be congenital or acquired. Although the exact etiology remains unknown, an obstructive process resulting from several causes, including infection, inflammation or malignant infiltration, has been suggested to be responsible for the acquired form. This disorder may be associated with several pathologies. We report a case of a 24-year-old man with renal lymphangiectasia presenting with polycythemia, ascites and pleural effusion associated with hepatitis C virus (HCV) infection in an intravenous (IV) drug user. Our case is the first in the literature that shows an association between HCV infection and IV drug use.
肾淋巴管扩张症是一种肾脏淋巴系统疾病,可分为先天性或后天性。尽管确切病因尚不清楚,但有人认为,包括感染、炎症或恶性浸润在内的多种原因导致的梗阻过程是后天性形式的病因。这种疾病可能与多种病理状况相关。我们报告一例24岁男性肾淋巴管扩张症患者,该患者为静脉注射毒品使用者,伴有红细胞增多症、腹水和胸腔积液,并感染丙型肝炎病毒(HCV)。我们的病例是文献中首例显示HCV感染与静脉注射毒品使用之间存在关联的病例。